DiagnoCure Inc. announced the appointment of Mr. Richard Bordeleau as Senior Advisor to the company effective September 1, 2013. Mr. Bordeleau will act as an executive in residence and report directly to DiagnoCure's board of directors. In collaboration with Company management, Bordeleau's initial mandate will be to identify and implement short term actions aimed at increasing shareholder value, and also to evaluate mid to long term scenarios optimizing corporate value.

Bordeleau joins DiagnoCure, following a highly successful international career in the life sciences industry. During his term as President of Atrium Innovations from 2000 to 2007, the company experienced sustainable double-digit organic growth through direct sales combined with international license and distribution agreements, augmented by multiple accretive acquisitions in North America and Europe. Mr. Bordeleau also more recently contributed to the growth of BioCad Medical, positioning the company as a leader in CADCAM dentistry.

Bordeleau currently manages investments in start-up companies together with members of Anges Quebec, a network of business angels where he initiated investments in life sciences as responsible of the health and well-being sector.